Having diabetes dramatically increases one’s risk of developing cancer, especially in women, as shown in a global review that involved nearly 20 million people.
Researchers have recently developed and validated an online health calculator called the Cardiovascular Disease Population Risk Tool (CVDPoRT) that can help people check their risk of heart disease and their heart age.
Health experts in the UK are alerting that rates of the sexually transmitted infection, mycoplasma genitalium, may probably double in the next decade, but there’s no need for the U.S. to panic. Tests that are becoming more accurate could only be the reason why there is an increase in rates. Mycoplasma genitalium is known to cause female infertility and it’s becoming resistant to antibiotics. This STI is often mistaken for chlamydia. Experts say that many patients are asymptomatic, which means they can spread the STI to their partners without knowing it.
A new study began investigating the association between sensitivity to bitter tastes and the risk of cancer in women. However, researchers were surprised to discover that their working hypothesis with regards to women’s sensitivity to bitter flavors had nothing to do with their long-term dietary preferences. The study findings were published in the European Journal of Nutrition.
Two new studies show that consuming a daily low-dose of aspirin could possibly help women avoid ovarian cancer or promote their survival if the disease starts to develop. A daily low-dose aspirin is linked to a 10% reduction in developing ovarian cancer and it is also associated with approximately 30% survival improvement for ovarian cancer patients.
A new study has revealed that a drug-resistant yeast species called Candida krusei is the same species as Pichia kudriavzevii that is used in food and biotechnology industries.
Endari, an FDA-approved medicine-grade version of the dietary supplement L-glutamine, has been proven effective in reducing the level of pain in patients suffering from sickle cell disease.
Australian genetic researchers have discovered that structural changes in human chromosomes could be responsible for the development of cancer and certain genetic diseases.
The world’s first blood test that can detect melanoma in its early stages has been established by scientists from Edith Cowan University.
With about half of the Australian population complaining of digestive issues, a new test has been created by Brisbane-based microbial genomics company, Microba, that can easily indicate problems with people’s digestive system and gut microbiome.